Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2024

Clinical features, treatment modalities, and survival rates of pediatric central nervous system tumors: A retrospective analysis from a single center (2000–2020)
Authors: Estera Bubláková, Miroslava Makohusová, Anna Ballová, Kristína Husáková, Stanislava Hederová, Andrea Mocná, Robert Chrenko, Svorad Trnovec, Salome Jakešová, Matúš Durdík, Boris Rýchly, Andrea Hrašková, Alexandra Kolenová
Neoplasma Vol.71, No.6, p.603–609, 2024
doi:10.4149/neo_2024_241030N441
Price: free access
[View Abstract]


Negative prognostic significance of primary cilia and cytoplasmic β-catenin expression in non-small cell lung cancer
Authors: Blanka Rosova, Alzbeta Filipova, Dimitar Hadzi Nikolov, Marie Drösslerova, Radoslav Matej, Aneta Rozsypalova, Igor Richter, Bohuslav Melichar, Rostislav Mahel, Radka Stepanova, Radka Lohynska, Josef Dvorak
Neoplasma Vol.71, No.6, p.594–602, 2024
doi:10.4149/neo_2024_241117N476
Price: free access
[View Abstract]


hsa_circ_0021727 facilitates esophageal squamous cell carcinoma progression by stabilizing GBX2 mRNA through interacting with EIF4A3
Authors: Jie Lin, Qiuping Zhu, Fanlin Zeng
Neoplasma Vol.71, No.6, p.581–593, 2024
doi:10.4149/neo_2024_240604N243
Price: free access
[View Abstract]


Disruption of lipid raft reverses drug resistance in colorectal cancer cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B pathway and P-glycoprotein
Authors: Jing Chen, Wei Zheng, Qian Li, RanRan Xu, TingTing Bai, Chao Pan
Neoplasma Vol.71, No.6, p.571–580, 2024
doi:10.4149/neo_2024_240422N179
Price: free access
[View Abstract]


circ_0075829 regulates ferroptosis and immune escape in colon cancer cells through the miR-330-5p/TCF4 axis
Authors: Huajun Fan, Yu Ding, Zhe Xiao, Shengbo Li, Yongbin Zheng
Neoplasma Vol.71, No.6, p.559–570, 2024
doi:10.4149/neo_2024_240803N328
Price: free access
[View Abstract]


MTHFD2 promotes breast cancer cell proliferation through IFRD1 RNA m6A methylation-mediated HDAC3/p53/mTOR pathway
Authors: Qingqing Zhang, Jun Mao, Luhan Xie, Ying Lu, Xiaobo Li, Xiaotang Yu, Lianhong Li
Neoplasma Vol.71, No.6, p.544–558, 2024
doi:10.4149/neo_2024_240719N305
Price: free access
[View Abstract]


IFIH1 promotes apoptosis through the TBK1/IRF3 pathway in triple-negative breast cancer
Authors: Chao Shi, Xiaohan Wang, Jingping Li, Shang Wu, Zhihui Liu, Xiaofei Ren, Xiangmei Zhang, Yunjiang Liu
Neoplasma Vol.71, No.6, p.533–543, 2024
doi:10.4149/neo_2024_240614N255
Price: free access
[View Abstract]


Methylation status of selected genes in non-small cell lung carcinoma – current knowledge and future perspectives
Authors: Adam Put, Katerina Smesny Trtkova, Jozef Skarda
Neoplasma Vol.71, No.6, p.511–532, 2024
doi:10.4149/neo_2024_240925N403
Price: free access
[View Abstract]


Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer
Authors: Xixi Ying, Zheng Shi, Rongjun Shao, Guangxian You, Zhengbo Song
Neoplasma Vol.71, No.5, p.509, 2024
doi:10.4149/neo_2024_231104N572COR
Price: free access
[View Abstract]


The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level
Authors: Martina Ondrušová, Martin Suchanský, Soňa Vándor Svidová, Gabriela Chowaniecová, Bela Mriňáková, Monika Sekerešová, Dominik Juskanič, Dalibor Ondruš, Michal Šenitko
Neoplasma Vol.71, No.5, p.498–508, 2024
doi:10.4149/neo_2024_240625N272
Price: free access
[View Abstract]


Comparative investigation among fluorescence in situ hybridization, DNA- and RNA-sequencing on detecting MYC, BCL2, and BCL6 rearrangements in high-grade B-cell lymphomas
Authors: Fen Zhang, Qian Cui, Haiwei Du, Xinze Lv, Ting Hou, Yu Chen, Jie Chen, Jian Liu, Jinhai Yan, Yanhui Liu
Neoplasma Vol.71, No.5, p.490–497, 2024
doi:10.4149/neo_2024_240527N236
Price: free access
[View Abstract]


Albumin bound-paclitaxel combined with anlotinib and immunotherapy in the second-line treatment of ES-SCLC: a retrospective cohort study
Authors: Xiaobing Li, De Wu, Jing Tang, Yuebing Wu
Neoplasma Vol.71, No.5, p.482–489, 2024
doi:10.4149/neo_2024_240716N299
Price: free access
[View Abstract]


Protein level of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in carcinoma of unknown primary
Authors: Eunah Shin, Ja Seung Koo
Neoplasma Vol.71, No.5, p.473–481, 2024
doi:10.4149/neo_2024_240701N280
Price: free access
[View Abstract]


Determination of serum vitamin D in patients with renal, bladder, and prostate cancer by ultra-performance liquid chromatography-tandem mass spectrometry
Authors: Zhenghong Huang, Wanxin Zhang, Kun Huang, Jiafu Feng
Neoplasma Vol.71, No.5, p.463–472, 2024
doi:10.4149/neo_2024_240802N325
Price: free access
[View Abstract]


Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K/AKT/mTOR pathway and DNMT1/E-cadherin methylation mechanism
Authors: Jianwang Li, Xiaozhen Cheng, Denggao Huang, Ronghua Cui
Neoplasma Vol.71, No.5, p.451–462, 2024
doi:10.4149/neo_2024_240511N214
Price: free access
[View Abstract]


Exploring the role of eIF3m in prostate cancer: regulation of c-Myc signaling pathway and therapeutic implications
Authors: Dongdong Guo, Cheng Ma, Jianyi Gu, Xinyu Zhai, Xinlin Chen, Guanqun Ju, Chuanmin Chu, Xiangyang Zhan, Tao Wang, Mingyue Tan, Dongliang Xu
Neoplasma Vol.71, No.5, p.442–450, 2024
doi:10.4149/neo_2024_240603N242
Price: free access
[View Abstract]


EIF4A3-induced circle RNA_ 0001860 promotes growth, invasion, and immune evasion of gastric cancer cells through the miR-618/HMGA2 axis
Authors: Xiaoyi Zhang, Jiaqi Li, Qian Zhang
Neoplasma Vol.71, No.5, p.428–441, 2024
doi:10.4149/neo_2024_240502N196
Price: free access
[View Abstract]


The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells
Authors: Lucia Demkova, Miroslava Matuskova, Katarina Gercakova, Zuzana Kozovska, Bozena Smolkova, Lucia Kucerova
Neoplasma Vol.71, No.5, p.417–427, 2024
doi:10.4149/neo_2024_240523N232
Price: free access
[View Abstract]


A response to: Artificial immortalization, number of therapy lines, and survival of patients with advanced gastric and esophagogastric adenocarcinoma
Authors: Vesna Bišof, Andrija Katić, Majana Soče, Marina Vidović, Jelena Viculin, Stjepko Pleština, Eduard Vrdoljak
Neoplasma Vol.71, No.4, p. 415–416, 2024
doi:10.4149/neo_2024_240618N262-R
Price: free access
[View Abstract]


Artificial immortalization, number of therapy lines, and survival of patients with advanced gastric and esophagogastric adenocarcinoma
Authors: Ivan Krečak Marko Skelin, Marko Lucijanić
Neoplasma Vol.71, No.4, p. 414–414, 2024
doi:10.4149/neo_2024_240618N262
Price: free access
[View Abstract]





Display #  
Results 1 - 20 of 56

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.